Targeted Therapies for Musculoskeletal Disorders
Advancing RNA and gene-based treatments to restore tissue integrity, reduce inflammation, and improve mobility in degenerative and genetic musculoskeletal conditions.
What Are Musculoskeletal Disorders?
Musculoskeletal disorders (MSDs) encompass a wide range of conditions affecting bones, muscles, cartilage, tendons, and ligaments. They can be degenerative (e.g., osteoarthritis), inflammatory (e.g., rheumatoid arthritis), traumatic (e.g., fractures), or genetic (e.g., muscular dystrophies).
MSDs are the leading cause of disability worldwide
Affect 1.7 billion people globally
Contribute to long-term healthcare costs
Our Therapeutic Focus
We are developing precision treatments for:
Osteoarthritis
Cartilage loss and joint degeneration
Muscular Dystrophies
Genetic disorders causing progressive muscle weakness.
Tendinopathies
Chronic tendon injury and inflammation.
Osteogenesis Imperfecta
Brittle bone disease.
Other rare musculoskeletal genetic disorders requiring targeted intervention. Suggested Graphic: Visual grid of joints and muscle fibres with clickable links to individual disease pages.
How MSDs Affect Patients
Common symptoms:
- Pain, swelling, and stiffness.
- Reduced range of motion.
- Muscle weakness or atrophy.
- Fatigue and mobility challenges.
Impact:
MSDs reduce quality of life, limit independence, and increase the risk of secondary complications such as falls and cardiovascular deconditioning.
Pain & Inflammation
Joint Stiffness
Muscle Weakness
Reduced Mobility
Existing Therapies and Their Limitations
Pain management
NSAIDs, corticosteroids, analgesics.
Surgical interventions
Surgical interventions
Physical rehabilitation
Physiotherapy and exercise regimens.
Limitations
Current therapies often address symptoms rather than underlying causes, and many surgical solutions have limited lifespan or require revision.
Restoring Structure and Function at the Cellular Level
We are harnessing gene and RNA technology to address the root causes of musculoskeletal disorders.
- Promote cartilage regeneration and restore joint function
- Repair muscle fibres and prevent progressive degeneration
- Reduce inflammation at the molecular level without systemic side effects
- Target therapy precisely to affected tissues for maximum benefit
Translating Science into Solutions
- Preclinical studies demonstrating cartilage regrowth and muscle repair.
- Development of tissue-targeted delivery systems for musculoskeletal tissues.
- Partnerships with orthopaedic and neuromuscular research institutes.
Working With the Musculoskeletal Community
We partner with orthopaedic, sports medicine, and genetic disorder foundations to:
- Share updates on regenerative therapy research.
- Support patient education and trial recruitment.
- Advocate for early intervention and lifestyle support.
Collaborating to Restore Mobility and Independence
We welcome collaborations with orthopaedic innovators, rehabilitation specialists, and research institutions to accelerate musculoskeletal therapy development.
